InvestSMART

Clover Corporation Limited (ASX:CLV)

ALERT: Price-sensitive ASX Announcement for CLV
Current share price for CLV : $0.900 0.155 (20.81%)+
Announcement
Release
24 Mar 2026 8:19AM
Price at Release
$0.745
Full Release
download
Summary
The Clover Corporation 1H FY26 Investor Presentation highlights strong financial performance, with gross margin improvement due to a favorable customer and product mix and an NPAT of $4.2 million, reflecting a significant increase from the previous year. Revenue growth was driven by new customer acquisitions and enhanced product mix, resulting in a robust balance sheet with $10.3 million in cash and no bank debt. Operational highlights include the continued development of new products like CholineXcel® and growth in DHA and ARA through product diversification. The Ecuador facility continues to supply tuna oil consistently, while the company anticipates further revenue growth in the second half of FY26, projecting revenue between $92 to $96 million.
Key Points
  • Gross margin improved due to favorable customer and product mix.
  • Operating costs increased to support growth.
  • NPAT result of $4.2m, up from $2.4m in 1H FY25.
  • Cash flow impacted by inventory build of oils against strong forecasts.
  • Revenue growth driven by new customer acquisitions and product mix.
  • Balance sheet remains strong with $10.3m cash and nil bank debt.
  • CholineXcel® being tested for packaging and shelf-life.
  • DHA and ARA growth supported by product diversification.
  • Ecuador facility provides consistent supply for tuna oil requirements.
  • FY26 revenue guidance is between $92 to $96m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.